Although there is evidence for the involvement of genes of serotonergic and dopaminergic systems in the manifestation of the Behavioural and Psychological Symptoms in Dementia (BPSD), genetic association studies are contradictory. We used 1008 probable AD patients from the UK and applied a Multiple Indicators Multiple Causes (MIMIC) approach to investigate the effect of 11 polymorphisms in the serotonergic and dopaminergic systems, on four behavioural sub-phenotypes, namely "psychosis"," moods", "agitation" and "behavioural dyscontrol", as well as on 12 NPI items. Significant findings included the association of DRD1 A48G with "psychosis" (p=0.037), the association of DAT1 VNTR with "agitation" (p=0.006) and the association of DRD4 with "moods" sub-phenotype (p=0.008). In addition, associations were identified between DRD1 A48G and DAT1 VNTR with aberrant motor behaviour (AMB) symptoms (p=0.001 and p=0.015 respectively), between DRD4 and sleep disturbances (p=0.018) and between 5HTTLPR and apathy (p=0.033). Finally, significant interactions were observed between COMT Val158Met and 5HTTLPR with "psychosis" (p=0.026), between HTTLPR and STin2 with "psychosis" (p=0.005), between DAT1 3'UTR VNTR and COMT Val158Met with "agitation" (p=0.0001) and between DAT1 3'UTR VNTR and 5HTTLPR with the "moods" factor (p=0.0027). The complexity of the interrelations between genetic variation, behavioural symptoms and clinical variables was efficiently captured by this MIMIC model.
This study aimed to investigate associations between risk alleles/genotypes and the presence of behavioural symptoms and sub-phenotypes, using data on eleven polymorphisms from ten genes, in a large cohort (n = 1008) of patients with probable AD. In addition to associations between genes and BPSD, potential interactions between polymorphisms which may affect the expression of these behavioural symptoms were investigated. Interactions were also investigated between the X-linked genes and gender to capture sex-specific effects. All of the polymorphisms were chosen because they have been previously associated with neuropsychiatric conditions such as depression or schizophrenia and all of them bar one (DRD2 Taq1) have been previously associated with behavioural symptoms in AD.
The fact that behavioural symptoms in AD tend to co-occur has led to the suggestion that distinct behavioural sub-phenotypes exist. We have previously proposed a Multiple Indicators Multiple Causes (MIMIC) model to capture the complexity of the interrelations between behavioural symptoms, sub-phenotypes and clinical variables, in the same dataset (26). Four behavioural sub-phenotypes, namely "psychosis", "moods", "agitation" and "behavioural dyscontrol" were identified and their associations with each other, as well as with covariates such as cognitive impairment, gender, age of onset and disease duration and each other were modelled. MIMIC models have been successfully applied in geriatric research (27-29), psychiatric studies (30;31) as well gene X environment studies (32). In the current study we aimed to use this model as a platform to test the association between risk alleles/genotypes with these behavioural symptoms and sub-phenotypes in the presence of covariates. This is a powerful approach which allows us to perform a simultaneous analysis of the entire system of variables, by forming specific hypotheses. Such systematic analysis will help shed light into the biological nature of these common and disabling symptoms in AD.
METHODS

Subject cohorts
We have used a UK cohort comprising of more than 1000 participants from the 
Genotyping analyses
DNA was available for all 1008 patients.
Genotyping of Single Nucleotide Polymorphisms (SNPs)
The genotypes of the 5HT2A C102T (rs6313), 5HT2C Cys23Ser (rs6318) , DRD1 -48A/G (rs4532), DRD2 A1 allele (rs1800479), DRD3 Gly9Ser (rs6280) and COMT Val158Met (rs4680) polymorphisms were determined by allelic discrimination assays based on fluorogenic 5' nuclease activity: TaqMan Single Nucleotide Polymorphism (SNP) Genotyping Assay (Applied Biosystems,). SNP-specific primers and probes were designed and assays were performed according to the manufacturer's instructions.
Genotyping of Variable Number Tandem Repeats (VNTRs)
Genotyping of the 5HTTLPR, STin2, MAOA and DAT1 VNTRs was performed using protocols described elsewhere with few modifications (8;35-37) (Supplement Methods 1).
Statistical analyses
All polymorphisms were investigated for significant departure from the HardyWeinberg Equilibrium (HWE) using the program PLINK (38). Associations between risk alleles/genotypes for each SNP were examined using the same MIMIC model method described in (26 This process was used in order to identify direct associations between a polymorphisms and symptoms. After this, a significant effect of the polymorphism on the latent variable would imply differences on the latent mean score. To simplify interpretation, associations were performed assuming no directionality between the factors but measuring their correlations after adjusting for the rest of the variables instead.
As 
Power Calculations
Power calculations were performed using the program QUANTO (41).
RESULTS
The key demographic characteristics of the 1008 patients are presented on Table 1 and the frequencies of the alleles examined for each polymorphism are presented in Table 2 . Power calculations were made using the allele frequencies in Table 2 . For a quantitative trait design and unrelated individuals, assuming a type I error rate of 0.05 and using a two-sided test, this study gave us >75% power to detect the effect a gene with a minor allele frequency of 0.1 explaining a 1% proportion of variance of a trait and >75% power to detect a significant interaction between two genes with a minor allele frequencies of 0.1 which explains 1% proportion of variance. These power values were obtained assuming a recessive mode of inheritance, and are therefore greater when dominant or additive models were used.
Multiple Indicators Multiple Causes (MIMIC) models
A. MIMIC model using covariates only
An initial model to assess the effect of covariates on the factor structure was created In addition correlations rather than directions between the four factors were modelled and therefore some small differences to the previously published model were observed (Supplementary Table 1 ).
Supplementary Table 1 and Supplementary Figure 1 show the associations between covariates and the four factors. Stepwise backwards regression was used as described to generate the model with the best fit. Overall the model had a good fit (χ 2 =95.459, df=85, p=0.225, RMSEA=0.011, CFI=0.993), and the five covariates (Gender, age/age of onset, MMSE, disease duration and psychotropic medication) explained 14.3% of the variability of "psychosis" factor, 8.6% of the variability of "agitation" factor, 13.3% of the variability of "moods" factor and 32% of the variability of "behavioural dyscontrol" factor.
B. MIMIC model using covariates and polymorphisms.
A MIMIC model was then built by adding simultaneously all the polymorphisms described in Table 2 . For the DAT1, HTTLPR and DRD4 polymorphisms individual models were first tested and only the alleles of each polymorphism showing significant associations or trends were added in the final model. Stepwise backward regression was used as before.
Adding the polymorphisms in the model indicated a significant association between DRD1 A48G G allele and lower "psychosis" levels (β=-0.093, SE=0.251, p=0.026).
A significant association was also observed between DAT1 10R allele and higher Table 2 ). The inclusion of the polymorphisms in the final model predicted an additional ~1%,~2% and ~1% of the variation of the "psychosis"
"agitation" and "moods" factors respectively but it failed to predict any additional variation of the "behavioural dyscontrol" factor. The model had a good fit (χ 2 =169.912, df=224, p=0.997, RMSEA=0.011, CFI=0.993) and was a significant improvement to the model where no genetic variation was added (Supplementary Table 3 ).
C. MIMIC model using covariates, polymorphisms and interactions between polymorphisms.
The final model allowed for the investigation of specific interactions between different polymorphisms. We looked for interactions between the polymorphisms which showed significant associations with BPSD in the previous model and between polymorphisms that have been reported to interact with each other in previous studies examining BPSD or other neuropsychiatric disorders. In more detail, we investigated whether the DAT polymorphism interacts with DRD1 or DRD4 polymorphisms, whether the DRD1 polymorphism interacts with DRD3 or DRD4 polymorphisms, whether the COMT polymorphism interacts with HTTLPR, MAOA, or DAT polymorphisms, whether HTTLPR interacts with DAT, MAOA, DRD4 or STin2 polymorphisms and finally whether the MAOA polymorphism interacts with DRD4
polymorphism. All of the interactions were added in the previous model where only direct associations with the polymorphisms were included and the final model was produced by using stepwise backwards regression and the Satorra-Bentler scaled chisquare test as before. In addition to the hypothesised interactions between polymorphisms, we also hypothesised that the effect of the MAOA and 5HT2C polymorphisms may be modified by gender, since both genes are on the X chromosome and gender specific association have been reported for both.
As seen in Table 1 , all of the previously observed associations between polymorphisms and sub-phenotypes or NPI items remained significant. A very significant interaction was observed between the DAT1 10R and the COMT G alleles. Patients carrying the 10R allele but no COMT G allele (AA carriers) had significantly lower "agitation" levels (β=-0.395, SE=0.563, p=0.0001) ( Figure 2 ). As seen above, DAT1 10R was significantly associated with higher "agitation" levels and this association was independent of COMT G allele. However, absence of DAT1 10R
allele was significantly associated with lower levels of "agitation" only in the absence of COMT G allele.
We also observed an interaction between the HTTLPR SS genotype the COMT G allele. Bearers of the HTTLPR SS genotype who did not bear COMT G allele had significantly higher "psychosis" levels (β=-0.261, SE=0.657, p=0.0255) ( Figure 2 ).
Another significant interaction was observed between the HTTLPR SS genotype and the STin2 12R allele. Patients bearing the HTTLPR SS genotype who did not carry a STin2 12R allele had significantly higher "psychosis" levels (β=-0.481, SE=1.103, p=0.0008) (Figure 2 ).
Finally, a significant interaction was observed between the HTTLPR S and the DAT1 10R alleles. Patients who carried neither the HTTLPR S allele nor the DAT1 10R allele had significantly lower "moods" factor level (β=-0.597, SE=0.634, p=0.0027) compared to those carrying both or either ( Figure 2 ). In addition, bearers of an S allele who did not carry an 10R allele had significantly higher "moods" levels compared to carriers of an S allele who did carry a 10R allele.
No significant interactions were observed between the rest of the hypothesised interactions except for a marginal interaction between DRD1 and DRD3. It was however not included in the final model since it did not result in significant fit improvement, in contrast to the rest of the interactions.
No interactions were observed between either the MAOA or the 5HT2C genes and gender except for a weak trend between the absence of high activity MAOA 4R and male gender with agitation (p=0.07; not included in the final model).
In the presence of these interactions a significant association was also observed between the presence of the HTTLPR genotype and higher apathy (β=0.074, SE=0.372, p=0.033).
The final model is presented in Table 3 and Figure 1 and had a very good fit (χ 2 = 209.72 df=274, p=0.998, RMSEA=0, CFI=1) and had a significantly better fit than the models which included covariates only or genetic associations with no interactions (Supplementary Table 3 ). This model explained 19.9% of "psychosis", 11.5% of "agitation", 17% of "moods" and 32% of "behavioural dyscontrol" factor, showing that the interactions predicted an additional 1-3% of the variation of the subphenotypes. Associations between the covariates are depicted in Figure 1 (Left side).
Lower MMSE was significantly associated with longer disease duration, male gender and lack of psychotropic medication use (all p<0.0001). In addition, older age/age of onset is associated with female gender (p=0.0078) and with shorter disease duration and lack of drug use (both p<0.0001). Finally, long disease duration was associated with use of psychotropic medication (p= 0.0017).
DISCUSSION
A number of studies have examined the association of polymorphisms in the serotonergic and dopaminergic system with BPSD but with conflicting results. This may partly be a consequence of due of small sample sizes and differences in approaches employed. This study has utilised the largest AD cohort so far to investigate the association of polymorphic variation in the dopaminergic and serotenergic systems with BPSD. It is also the first study to employ a systematic MIMIC approach to investigating simultaneously the association of 11 common polymorphisms and their interactions with both the behavioural sub-phenotypes and the individual NPI symptoms in AD patients, in the presence of covariates. This study had a minimum of 75% power to detect significant associations and interactions that explain at least 1% of the variance of each trait (R 2 ) for common alleles (MAF=0.1).
Increasing allele frequencies resulted in power estimates of almost 99%.
This study has replicated some previously reported associations between BPSD and polymorphisms of the serotonergic and dopaminergic pathways but has also identified some novel associations. In addition, this study reports novel interactions between polymorphisms which may highlight epistatic effects.
A significant association was identified between DRD1 A48G G allele and "psychosis" sub-phenotype. Allele G corresponds to the B1 allele in the studies published by Sweet et al., and Holmes et al., (15;23). It is interesting that both these studies identified an association between DRD1 A48G and psychotic symptoms, although the reported allele/genotype frequencies were not in full agreement. Here, we replicate the finding of Sweet and partly that of Holmes and report an association between the presence of allele G (GG and GA) and lower level of "psychosis" factor.
Of note, a similar association between DRD1 A48G and psychosis has been reported in young adults with schizophrenia (42). This is the first study to report an association of DRD1 A48G with AMB. As with the association with "psychosis", allele G was associated with lower AMB symptoms.
Although the most recent to date investigating the association of DRD1 A48G and BPSD (21) did not identify any significant associations, the present study employs a much larger cohort and in addition, the cohort of Pritchard et al (52) had moderate cognitive impairment (mean MMSE =18.6) compared to the present cohort (Table 1) .
Of note, our study does not report an association between "psychosis" and the 5HT2A
C102T SNP, which reported in a recent meta-analysis (43) to be significantly associated with psychotic symptoms in AD.
Our findings of a significant association between DAT1 3'UTR VNTR and AMB are consistent with previous data (19). In addition, we identified a significant association between the DAT1 10R allele and higher scores of the "agitation" sub-phenotype. The finding between the DAT1 VNTR and "agitation" is an intriguing one, since the polymorphism has been implicated in violent and anti-social behaviour in adolescents This study also identified a trend between the DRD3 BalI polymorphism and the "moods" factor. Only one study (21) has investigated the association between DRD3
BalI and depression, failing however to report any significant associations. DRD3
BalI has been previously implicated in depressive disorders, although meta-analyses have shown a weak association (48).
A number of significant interactions between different polymorphisms were also identified. Epistatic interactions have been rarely investigated in BPSD and only two study to date (23;49) has reported additive effects between COMT and HTTLPR, as well as between DRD1 and DRD3 on psychosis. Specific hypotheses on the effect of epistatic interactions on the behavioural sub-phenotypes and the individual NPI items were tested based on the results from the initial models and previously published associations.
The effect of DAT 10R on "agitation" seemed to be modified by the COMT G allele whereby in the absence of COMT G allele (AA genotype), the DAT1 10R allele was significantly associated with lower levels of "agitation", whereas in the presence of Finally an interaction was also identified between the absence of both the HTTLPR S and the DAT1 10R alleles which resulted in significantly lower "moods" levels (or between HTTLPR S carriers carrying no DAT1 10R allele which had significantly higher "moods" levels). Both HTTLPR and DAT1 are responsible for the clearance of serotonin and dopamine respectively from the synaptic cleft and are both implicated in depressive disorders and response to anti-depressant treatment, and interactions between the two polymorphisms have been associated with harm avoidance and reward dependence traits (61-66).
The significant interactions identified in this study highlight the complexity of the relationships between genes of the dopaminergic and serotonergic systems and BPSD.
Monoaminergic systems are interconnected and serotonergic projections from the dorsal raphe nuclei project directly to the substantia nigra and inhibit the firing of dopaminergic neurons (67) . Interactions therefore between genes involved in the two systems, which may modulate behaviour, are very interesting. However, it has to be highlighted that although the present study is well powered to detect these interactions, the combination of allele responsible for the significant effects observed were present in 2-7% of the patients which highlights the need for even larger cohorts.
The significant genetic associations and interactions reported here were weak and individually only explained an addition 1-5% of each trait investigated, as expected when investigating behavioural phenotypes. Overall the presence of covariates and genetic variation explained ~ 20%, 12% 17% and 32% of the variation of "psychosis", "agitation", "moods" and "behavioural dyscontrol" factors respectively highlighting that there is a large proportion of unexplained variation. In summary, the model in Figure 1 highlights the necessity of systematic statistical approaches such as MIMIC modelling to be used when investigating the genetic nature of BPSD. This model can be used in future approaches to test for the association of behavioural sub-phenotypes with other candidates polymorphisms in a simultaneous analysis of the entire system. All paths drawn indicate significant associations (p<0.05) except for association between elation and "behavioural dyscontrol" (p=0.20). The four factors were significantly associated with each other at the 0.001 level (correlation of "psychosis" with "agitation", "moods" and "behavioural dyscontrol" factors was ρ=0.425, ρ=0.222, ρ=0.313, correlation of "agitation" with "moods" and "behavioural dyscontrol" was ρ=0.303 and ρ=0.488 and correlation between "moods" and "behavioural dyscontrol" ρ=0.588 respectively). 
